European Commission
Public Health
Accessibility tools
Service tools
Language selector
- Current languageen
Navigation path
- European Commission
- Public health
- Reference documents
- Register
- Orphan products
- 1,2-bis(methylsulphonyl)-1-(2-chloroethyl)-2-[(methylamino)c
Community Register of medicinal products
Community register of orphan medicinal products | GRANTED |
Product information |
1,2-bis(methylsulphonyl)-1-(2-chloroethyl)-2-[(methylamino)carbonyl]hydrazine
| EU orphan designation number: | EU/3/05/332
|
| Active ingredient: | 1,2-bis(methylsulphonyl)-1-(2-chloroethyl)-2-[(methylamino)carbonyl]hydrazine |
| Indication: | Treatment of acute myeloid leukaemia |
| Sponsor: | Vion (UK) Limited, ? i3 Research
Sygnus Court , 22-32 Market Street, Maidenhead SL6 8AD, United Kingdom |
Public summary of scientific opinion
European Commission procedures
| Close date procedure | Procedure type | EMEA number | Decision | summary publ | decision docs | annex |
| 16/12/2005 | Centralised Orphan - Designation | EMEA/OD/066/05 | (2005)5627 of 14/12/2005 |